M7T.AX - Mach7 Technologies Limited

ASX - ASX Delayed Price. Currency in AUD
0.00 (0.00%)
At close: 3:25PM AEST
Stock chart is not supported by your current browser
Previous close0.21
Bid0.00 x 0
Ask0.00 x 0
Day's range0.21 - 0.21
52-week range0.14 - 0.38
Avg. volume42,022
Market cap27.756M
PE ratio (TTM)N/A
EPS (TTM)-0.04
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswirelast month

    EnvoyAI Partners with Mach7 Technologies to expand AI to Enterprise Imaging, VNA, and PACS

    CAMBRIDGE, Mass., Aug. 07, 2018-- Artificial intelligence platform provider, EnvoyAI, has entered into a distribution deal with Mach7 Technologies, a leading enterprise imaging solution provider. The deal ...

  • PR Newswire5 months ago

    Mach7 Welcomes New Reconstructed PACS Customer, Announces Customer Expansions and Customer Go Lives

    BURLINGTON, Vt ., April 25, 2018 /PRNewswire/ -- Mach7 Technologies announces a business update for the quarter ended March 31, 2018 demonstrating great momentum moving toward the end of their fiscal year. ...

  • PR Newswire10 months ago

    Mach7 and SirenMD Announce Partnership for Collaboration to Leverage Data for Enhanced Patient Care

    SirenMD harnesses the power of Sage, Mach7's Data Services Platform, to provide organized aggregated clinical data to a team of providers for seamlessly coordinated patient care. CHICAGO, Nov. 29, 2017 /PRNewswire/ -- Mach7 Technologies (M7T.AX), a global market leader in data management solutions, announced today on the RSNA exhibition floor their partnership with SirenMD for innovative product development. SirenMD is a workplace collaboration platform designed to increase the quality, efficiency, and timeliness of medical decisions by facilitating coordinated communication between caregivers and patient advocates (doctors, nurses, athletic trainers, and other medical personnel).